Across TCGA pan-cancer cohorts, HNRNPA1P68 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P68’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where HNRNPA1P68 RNA is repressed in tumor relative to normal tissue. In most cancer types HNRNPA1P68 is over-expressed in tumor, although a few such as THCA and COAD show the opposite, repressed pattern.

THCA, CHOL, and KIRC are the cancer types where HNRNPA1P68 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P68 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	IV	−0.210	.043	2	view →
CHOL	Female	All	+0.186	<.001	2	view →
KIRC	All	All	+0.033	.005	2	view →
LIHC	All	All	+0.020	.019	2	view →
COAD	Female	IV	−0.090	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: HNRNPA1P68 RNA expression & survival · all HNRNPA1P68 data types